The projected timeframe until cervical cancer elimination in Australia: a modelling study.

  title={The projected timeframe until cervical cancer elimination in Australia: a modelling study.},
  author={Michaela T Hall and Kate T Simms and Jie-Bin Lew and Megan A. Smith and Julia M. L. Brotherton and Marion Saville and Ian H. Frazer and Karen Canfell},
  journal={The Lancet. Public health},
  volume={4 1},

Figures from this paper

Projected time to elimination of cervical cancer in the USA: a comparative modelling study.
Achieving cervical cancer elimination among Indigenous women.
Modelling cervical cancer elimination.
Lessons from the renewal of the National Cervical Screening Program in Australia.
This analysis of the national program's transition to a new model looks at the lessons learnt that can provide valuable insights to other settings, including other countries making similar changes to cervical screening.
Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK
Vaccinating girls is extremely cost-effective compared with no vaccination, vaccinating both sexes is less so, and adding boys to an already successful girls-only programme has a low cost-effectiveness, as males have high protection through herd immunity.
Preventing Cervical Cancer Globally: Are We Making Progress?
Successful implementation of all 3 steps could reduce more than 40% of new cervical cancer cases and 5 million related deaths by 2050, but this initiative requires high level commitment to HPV immunization programs, innovative approaches to screening, and strengthening of health systems to provide treatment for both precancerous lesions as well as invasive cervical cancer.


Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study
A population-based HPV vaccination program in schools significantly reduced cervical abnormalities for vaccinated women within five years of implementation, with the greatest vaccine effectiveness observed for the youngest women.
Fall in human papillomavirus prevalence following a national vaccination program.
A substantial decrease in vaccine-targeted genotypes is evident and should, in time, translate into reductions in HPV-related lesions.
Cervical screening in HPV-vaccinated populations
  • K. Canfell
  • Medicine
    Climacteric : the journal of the International Menopause Society
  • 2018
How the benefits of HPV screening are being optimized in both unvaccinated and vaccinated populations is described, which includes introducing effective triaging for HPV-positive women, which further risk-stratifies women before referral for diagnostic evaluation.
Trends in genital warts by socioeconomic status after the introduction of the national HPV vaccination program in Australia: analysis of national hospital data
The relative reduction in genital warts appears similar in young females across different levels of disadvantage, including within and outside major cities, both for females predominantly vaccinated at school and in the community.
Very Low Prevalence of Vaccine Human Papillomavirus Types Among 18- to 35-Year Old Australian Women 9 Years Following Implementation of Vaccination
Prevalence of vaccine-targeted HPV types has continued to decline among young women, and a substantial fall also occurred in women aged 25-35, despite lower coverage.
Fall in genital warts diagnoses in the general and indigenous Australian population following implementation of a national human papillomavirus vaccination program: analysis of routinely collected national hospital data.
National population-based hospital data confirm previous clinic-based reports of a marked decline in genital warts diagnoses among young people in Australia after program implementation, including indirect benefits to males.